Life Sciences Market
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
Value-based Care, Patient Data Digitization, and Collaborative Technology Deployment Offer Investment Opportunities
Region : North AmericaThe pharmaceutical industry today is in a state of flux as it tries to maintain a delicate balance between the need for novel blockbuster drugs and the need for improved operational efficiencies in an increasingly competitive market space. As healthcare is becoming increasingly democratized, patients are emerging as key decision makers—digitally ...
Consumer Education and Exploring Alternative Markets Would Drive the Direct-to-Consumer Genetic Testing Market
Region : GlobalAs healthcare evolves toward personalized solutions, everyday consumers are proactively taking responsibility for their health in ways unimaginable a decade ago. A direct-to-consumer genetic test (DTCGT) exemplifies this trend which can be purchased and used directly by consumers without the requirement of a prescription from a healthcare provider....
Clinical Labs to Transform into Health Information Companies and Increasingly Participate in Clinical Decision Support
Region : EuropeDiagnostics has inarguably become an integral part of healthcare system, moving from reactionary science to predictive science; playing a vital role throughout the care continuum. While rising burden of chronic diseases, drug-resistant diseases and the increasing proportion of elderly population are the organic growth drivers, the shift towards cre...
Medical Cannabis Revenue will Overtake Recreational in the Next 4 Years
Region : GlobalThe medical marijuana market is growing in the United States despite the fact that the Food and Drug Administration (FDA) has not yet approved any medical marijuana products. These marijuana-based products have not yet passed through the rigorous tests and clinical trials required for medical drug approvals in the United States. At the Federal le...
Synopsis from World Café Discussions Held at Health IT Forum of Medica 2017
Region : GlobalHealthcare organizations face numerous challenges in today’s dynamic business environment, be it clinical, non-clinical or operational processes in hospitals. The industry is fundamentally focusing on digital transformational strategies, while increasing its investments in next-generation solutions such as clinical information systems, connected ...USD 1,500.00Read More
Unveiling One of the Most Promising Fields of Therapeutic Technology Synergy
Region : GlobalRecent advancement in the development of novel platforms of smart targeting small molecules, gene therapy, stem cell therapy, gene modification, and gene rectification technologies pose new prospects for therapies and cures for rare and genetic diseases. More than 80% of rare diseases are genetic in origin, so that gene and cell therapies are being...
Growth Insights for European Infectious Disease Point-of-Care Testing (POCT) Market, Forecast to 2022
Rise in Cases of Sepsis and Antimicrobial Resistance (AMR) Along with the Focus on Preventative Care will Drive POCT Growth Throughout the Forecast Period
Region : EuropeThe rise in infectious diseases across Europe has led to a growing need for early detection and diagnosis of infectious diseases in the region. Point-of-care testing (POCT) is a vital part of the clinical diagnostics market and is rapidly evolving into the preferred testing mode as rapid infection diagnosis results in lower antibiotic intake, fewer...USD 1,500.00Read More
Shift Towards a 'Comprehensive Care Continuum' with the Adoption of Integrated Care Pathways that Combine Clinical Therapies with Wellness Programs
Region : North AmericaThis is a premium access report. To purchase click on the buy now button. Use code: FROSTCMHC60 to access our promotional pricing Globally, cardiometabolic diseases are witnessing a consistent rise in prevalence every year, with hypertension and diabetes among the leading conditions. A rising population of hypertension is, in turn, leading to grow...
Focus on Integrative Solutions Combining Dietary Supplements and Aesthetic Solutions with Clinical Therapeutics as the Market Moves Toward a ‘Prevent-Manage-Repair’ Continuum
Region : North AmericaThis is a premium access report. To purchase click on the buy now button. Use code: FROSTA4M60 to access our promotional pricing The rapidly aging global population is placing immense pressure on healthcare systems across countries and regions. The improvement in life expectancy levels has created a large cohort of aged patients who suffer from ...USD 4,950.00read more
Wearables and Mobile Technologies Growth Opportunities in Digital Transformation Journey of Clinical Trials
Region : North AmericaClinical trial sponsors and clinical research organizations (CROs) are facing intense pressure to change the way clinical research is conducted and justify the costs and time involved in the clinical development process. Some of the prevailing challenges in the clinical trial industry include the complexity and cost of conducting clinical trials, t...